ArticleMolecular oncology2021

A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.

Mara Lecchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.